Name: Method for Efficient Refolding and Purification of Chemoreceptor Ligand Binding Domain (Video) | JoVE Journal
Uploaded: 2017-12-12T15:00:00.000+00:00
Duration: 14 min 25 s
Description: Learn efficient refolding and purification of the Tlp3 chemoreceptor ligand binding domain from inclusion bodies using E. coli expression. This method yields milligram quantities of functional protein for structural studies and ligand screening.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank Yu C. Liu for his early work on the Tlp3-LBD production. Mayra A. Machuca is indebted to Departamento Admistrativo de Ciencia, Tecnolog&#237;a e Innovaci&#243;n COLCIENCIAS for a doctoral scholarship.

1. Expression of His6-Tlp3-LBD&#160;in E. coli
<ol>
	<li>Inoculate 150 mL of sterile Luria-Bertani (LB) broth containing 50 &#181;g mL-1 ampicillin with BL21-Codon-Plus(DE3)-RIPL cells transformed with the pET151/D-TOPO vector for expression of His6-Tlp3-LBD (amino acid residues 42-291), and incubate it at 37 &#176;C in a shaker (orbit diameter, 25 mm) with 200 rpm overnight.</li>
	<li>Prepare six 2 L Erlenmeyer flasks containing 800 mL of sterile LB broth and 50 &#181;g mL-1 ampicillin. Inoculate each flask with 20 mL of the overnight culture obtained from step 1.1. Incubate them at 37 &#176;C with continuous shaking at 200 rpm until the optical density at 600 nm reaches 0.6.</li>
	<li>Take a 1 mL aliquot from one of the flasks (uninduced control sample), pellet using a benchtop centrifuge (13,000 x&#160;g, 4 &#176;C, 10 min) and discard the supernatant. Store the bacterial pellet at -20 &#176;C for subsequent SDS-PAGE analysis.</li>
	<li>Induce protein expression by adding 1 mM of isopropyl &#946;-D-thiogalactoside (IPTG) to each flask with culture. Continue incubating the flasks at 37 &#176;C in a shaker at 200 rpm for an additional 4 h.</li>
	<li>Harvest the cells by centrifugation at 5,000 x&#160;g for 15 min at 4 &#176;C and discard the supernatant. 
	NOTE: At this point, the procedure can be paused by placing the cell pellet into a -80 &#176;C freezer for storage.</li>
</ol>
2. Isolation and Denaturation of Inclusion Bodies
<ol>
	<li>Transfer all the cell pellets obtained in step 1.5 to a 250 mL beaker and add 100 mL of buffer A (10 mM Tris-HCl, pH 8.0, 150 mM NaCl). Allow the cells to thaw completely (if frozen), and resuspend the pellet. Keep the sample on ice unless indicated otherwise.</li>
	<li>Pass the resuspended cells through a high-pressure homogeniser three times to lyse the cells and ensure complete shearing of the genomic DNA.</li>
	<li>Centrifuge the lysate at 10,000 x&#160;g for 15 min at 4 &#176;C. Collect a 1 mL sample of the supernatant (soluble fraction) and store it at -20 &#176;C for subsequent SDS-PAGE analysis. Discard the rest of the supernatant and place the pellet on ice. 
	NOTE: This pellet is white in color (easily distinguishable from unbroken cells which are the shade of brown in color) and contains inclusion bodies.</li>
	<li>Resuspend the inclusion bodies pellet thoroughly in 20 mL of ice-cold buffer B (10 mM Tris-HCl pH 8.0, 0.2 mM phenylmethanesulfonyl fluoride (PMSF), 1% Triton X-100). This facilitates solubilisation of the membrane and membrane proteins. Vortex for 1 - 2 min to aid resuspension.</li>
	<li>Centrifuge the sample at 10,000 x&#160;g for 15 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the pellet thoroughly in 20 mL of ice-cold buffer B by vortexing the tube for 1 - 2 min. Ensure that the pellet is broken into small pieces. Pipet the sample up and down to aid pellet resuspension. 
	NOTE: It is important to resuspend the pellet thoroughly to obtain inclusion bodies free from impurities.</li>
	<li>Repeat step 2.5. If the supernatant is cloudy or coloured, repeat steps 2.6 and 2.5 (in that order) until the supernatant is clear and colourless.</li>
	<li>Resuspend the pellet in 20 mL of ice-cold buffer C (10 mM Tris-HCl pH 8.0, 0.2 mM PMSF) by vortexing the tube for 1 - 2 min.</li>
	<li>Repeat step 2.5.</li>
	<li>Add 25 mL of ice-cold denaturing buffer D (10 mM Tris-HCl pH 8.0, 8 M urea, 10 mM dithiothreitol (DTT), 0.2 mM PMSF) to dissolve the inclusion bodies pellet. Resuspend thoroughly by vortexing for 1 - 2 min, or until the pellet is broken into small pieces.</li>
	<li>Mix the suspension by axial rotation with a rotation rate of 30 rpm for 30 - 120 min at 4 &#176;C.</li>
	<li>Clarify the denatured protein solution by centrifugation at 30,000 x g, 4 &#176;C for 30 min, place the supernatant on ice and discard the pellet.</li>
	<li>Measure the protein concentration using the Bradford assay.24 Take an aliquot for SDS-gel analysis and place it at -20 &#176;C. 
	NOTE: At this point, the procedure can be paused by snap-freezing the aliquoted sample in liquid nitrogen and keep it at -80 &#176;C for storage.</li>
</ol>
3. Protein Refolding
<ol>
	<li>Prepare 250 mL of buffer E (3 M urea, 100 mM Tris-HCl pH 8.0, 0.4 M L-arginine monohydrochloride, 20 mM reduced L-glutathione, 2 mM oxidized L-glutathione) in a 500 mL beaker and cool the buffer down to 4 &#176;C.</li>
	<li>Add 60 mg of denatured protein mix containing His6-Tlp3-LBD obtained in step 2.13 to 250 mL of buffer E, while stirring the buffer at 500 rpm. Incubate the refolding mix at 4 &#176;C with continuous stirring at 500 rpm for 24 - 48 h. The final protein concentration in this step is 0.2 mg mL-1.</li>
	<li>Prepare 7 L of buffer A in an 8 - 10 L bucket and cool it down to 4 &#176;C in preparation for the next step (step 3.4) that will take place in 24 - 48 h (see the flowchart in Figure 1).</li>
	<li>Immerse an ~50 cm piece of dialysis tubing of 28 mm inflated diameter, with molecular weight cut-off at 12 - 14 kDa into 200 mL of 10 mM ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) and heat it over a gas flame until boiling. Rinse the dialysis membrane with 200 mL of ddH2O.</li>
	<li>Clamp one end of the dialysis membrane with a dialysis tubing closure and transfer the 250 mL refolding mixture obtained in step 3.2 into the dialysis tube. Close the open end with another clamp. Check the integrity of the membrane to ensure there are no leaks.</li>
	<li>Place the dialysis tube in a dialysis bucket with the pre-cooled 7 L of buffer A prepared in step 3.3. Place a magnetic stir bar, ensuring that it will not touch the dialysis tubing while stirring.</li>
	<li>Dialyse the sample at 4 &#176;C with continuing stirring at 500 rpm and change the buffer at least four times over a period of 12 h. After the last buffer change, leave the sample to dialyse overnight. 
	NOTE: During dialysis, the excess of urea (~3 M) is gradually removed from the denatured protein solution, which allows the protein to refold. Heavy protein precipitation can be observed at the end of dialysis.</li>
	<li>Remove the dialysis tube from the bucket and transfer its contents into a 500 mL beaker. Keep the protein solution on ice, unless indicated otherwise.</li>
	<li>Filter the protein solution through a 0.43 &#181;m pore size membrane into a 500 mL glass bottle to remove any precipitated protein.</li>
</ol>
4. Purification of His6-tagged Protein Using Immobilised Metal Ion Affinity Chromatography
<ol>
	<li>Charge and equilibrate a 5 mL prepacked chelating column.
	<ol>
		<li>Connect the column to a peristaltic pump, ensuring that there is no air trapped in the connecting tubing.</li>
		<li>Wash the column by passing through 25 - 50 mL of ddH2O.</li>
		<li>Charge the column by loading 3 mL of 0.1 M NiCl2 and then passing through 25 mL of ddH2O.</li>
		<li>Equilibrate the column with 25 mL of buffer F (loading buffer, 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM imidazole).</li>
	</ol>
	</li>
	<li>Adjust the refolded protein sample obtained in step 3.9 to the composition of buffer F by adding 2.5 mL of 1 M Tris-HCl pH 8.0, 25 mL of 5 M NaCl and 2.5 mL of 2 M imidazole stock solutions.</li>
	<li>Load the sample onto the column at a rate of 5 mL/min or less and discard the flow-through (unbound proteins).</li>
	<li>Wash the column with 50 - 100 mL of buffer F to remove non-specifically bound proteins and discard the flow-through.</li>
	<li>Elute His6-Tlp3-LBD with 25 mL of buffer G (elution buffer, 20 mM Tris-HCl, 500 mM NaCl, 500 mM imidazole) and pool the flow-through fractions containing the protein (as determined by using the Bradford reagent).</li>
	<li>Measure the protein concentration in the pooled sample using the Bradford assay. Take a small aliquot for SDS-PAGE analysis and place at -20 &#176;C.</li>
</ol>
5. His6-tag Removal Using TEV Protease (Optional)
<ol>
	<li>Prepare, and cool down to 4 &#176;C, 4 L of buffer H (TEV cleavage buffer, 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 % (v/v) glycerol, 2 mM DTT).</li>
	<li>Cut approximately 5 - 7 cm of dialysis tubing (diameter 2 - 3 cm) and immerse it in 200 mL of ddH2O.</li>
	<li>Add His6-tagged TEV protease to the His6-tag protein prepared in step 4.5 to a final molar ratio 1 TEV: 8 protein.</li>
	<li>Clamp one end of the tubing with a dialysis tubing closure and fill it with the protein/TEV protease mixture. Close the other end and ensure there are no leaks.</li>
	<li>Place the dialysis tube into the pre-cooled 4 L of buffer H (from step 5.1) and incubate it at 4 &#176;C with continuous stirring for 2 h. Change the buffer and continue dialysis overnight to allow the TEV-mediated cleavage reaction to complete.</li>
	<li>In the meantime, prepare and cool (4 &#176;C) 4 L of buffer I (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 % (v/v) glycerol) in preparation for the next day.</li>
	<li>After the overnight dialysis, exchange the buffer to buffer I prepared in step 5.6 and dialyse for a further 1 - 2 h at 4 &#176;C.</li>
	<li>Remove the tube from the dialysis bucket, unclip one end of the tube and transfer the protein solution to a 50 mL Falcon tube. Filter the solution through a 0.43 &#181;m pore size syringe filter and keep it on ice, unless stated otherwise.</li>
	<li>Measure the volume of the sample and adjust the Tris, NaCl and imidazole concentration to the composition of buffer F (e.g. for 25 mL of protein solution in buffer J add 0.25 mL of 1 M Tris-HCl pH 8.0, 1.75 mL of 5 M NaCl, and 0.25 mL of 2 M imidazole).</li>
	<li>Prepare a 5 mL HiTrap Chelating HP column as described in step 4.1.</li>
	<li>Load the sample onto the column (flow rate: 5 mL/min) and collect the flow-through, which contains the untagged Tlp3-LBD (residues 42 - 291). Uncleaved protein, the cleaved His6-tag and His6-TEV are retained by the column.</li>
	<li>Wash the column with 5 mL buffer F (loading buffer) to allow all untagged protein to flow through and collect the eluate.</li>
	<li>Pool the eluate obtained in steps 5.11 and 5.12 and measure the protein concentration. Take a small aliquot and store it at -20 &#176;C for SDS-PAGE analysis.</li>
</ol>
6. Size-exclusion Chromatography (Gel Filtration) of Tlp3-LBD
<ol>
	<li>Prepare 1 L of buffer A (10 mM Tris-HCl pH 8.0, 150 mM NaCl) and filter it using a 0.43 &#181;m membrane.</li>
	<li>Equilibrate a 26/60 size-exclusion column with buffer A at a flow rate of 4 mL/min.</li>
	<li>Concentrate the protein sample obtained in step 5.13 to a volume of 3 - 4 mL using 15 mL centrifugal concentrator with a 10 kDa cut-off (4 &#176;C, 4,000 x&#160;g).</li>
	<li>Clarify the protein solution by centrifugation at 13,000 x&#160;g, 4 &#176;C for 30 min to remove any precipitated protein.</li>
	<li>Load the sample onto the pre-equilibrated 26/60 gel filtration column. Perform chromatography in buffer A at a flow rate of 4 mL/min. Monitor the UV trace. Tlp3-LBD elutes at a retention volume of 210 - 220 mL. Pool the peak fractions.</li>
	<li>Measure the protein concentration. Take a small aliquot for SDS-PAGE analysis.</li>
</ol>
7. SDS-PAGE Analysis of Samples Collected at Various Stages of Protein Purification
<ol>
	<li>Prepare 1 L of SDS-PAGE running buffer (buffer J), containing 25 mM Tris, 250 mM glycine pH 8.3, and 0.1 % (w/v) sodium dodecyl sulfate (SDS).</li>
	<li>Prepare 10 mL of 5x SDS-PAGE loading buffer (buffer K), containing 0.25 M Tris-HCl pH 6.8, 10% (w/v) SDS, 50% (v/v) glycerol, 1 mM DTT, and 0.05% bromophenol blue.</li>
	<li>Allow the aliquots collected during the different steps of the purification (steps 1.3, 2.3, 2.13, 4.6, 5.13, 6.6) to thaw.</li>
	<li>For each sample, mix the volume corresponding to 15 &#181;g of total protein with 2 &#181;L of 5x&#160;SDS-PAGE loading buffer, and adjust the volume to 10 &#181;L with ddH2O.</li>
	<li>Heat the samples at 95 &#176;C for 5 - 10 min, spin them at 10,000 x&#160;g for 30 s and transfer the samples into a clean tube.</li>
	<li>Prepare an SDS-PAGE gel, using 15% polyacrylamide separating gel (for 5 mL: 2.5 mL 30% (w/v) bis-acrylamide, 1.2 mL 1.5 M Tris-HCl pH 8.8, 1.2 mL ddH2O, 50 &#181;L 10% (w/v) SDS, 50 &#181;L 20% (w/v) ammonium persulfate (APS), 3 &#181;L tetramethylethylenediamine (TEMED) and 5% polyacrylamide stacking gel (for 2 mL: 340 &#181;L 30% (w/v) bis-acrylamide, 250 &#181;L 1 M Tris pH 6.8, 1.37 mL ddH2O, 20 &#181;L 10% (w/v) SDS, 20 &#181;L 20% (w/v) APS, 2 &#181;L TEMED).</li>
	<li>Assemble the electrophoresis apparatus and fill it with 1x SDS page running buffer as per manufacturer&#39;s recommendation.</li>
	<li>Load a protein molecular weight marker and the samples prepared in step 7.5. Perform the electrophoresis at a constant current of 25 mA.</li>
	<li>Transfer the gel into a container and rinse it with ddH2O. Add 150 mL of the Coomassie Blue staining solution containing 25% (v/v) isopropanol, 10% (v/v) acetic acid and 0.03% (w/v) Brilliant Blue R-250. Place the container on a horizontal rotation platform for 30 min at room temperature.</li>
	<li>Rinse the gel with ddH2O and place into the destaining solution containing 5% (v/v) methanol and 7% (v/v) acetic acid. Destain while mixing using a horizontal rotation platform for 1 h.</li>
	<li>Image the gel and analyse.</li>
</ol>
8. Circular Dichroism (CD) Spectroscopy Analysis of Secondary Structure of refolded Pure Protein
<ol>
	<li>Transfer 0.5 - 1 mg of refolded protein obtained in step 6.6 into a dialysis tube and place it in a dialysis bucket containing 5 L of buffer L (50 mM sodium phosphate pH 7.4), precooled to 4 &#176;C. Dialyse the sample at 4 &#176;C with continuous stirring and perform at least 3 - 4 buffer changes over 2 - 4&#160;h before leaving the sample to dialyse overnight.</li>
	<li>Concentrate the dialysed protein solution to 0.06 mg mL-1 using a 10 kDa cut-off centrifugal concentrator.</li>
	<li>Clarify the solution by centrifugation at 13,000 x&#160;g, 4 &#176;C for 30 min.</li>
	<li>Record the far-UV CD spectrum of the sample at 25 &#176;C over a wavelength range of 200 - 260 nm using a spectropolarimeter with a scan rate of 20 nm min-1. Use the dialysis buffer as a blank control. Repeat recording in triplicate and generate the averaged spectrum.</li>
	<li>Calculate the secondary structure content by deconvoluting the CD spectra using the CDSSTR program from the DichroWeb sever25 (http://dichroweb.cryst.bbk.ac.uk).</li>
</ol>

The authors declare no competing financial interests.

A simple procedure for expression and refolding from inclusion bodies of the periplasmic LBD of the bacterial chemoreceptor Tlp3 is presented. Preparation of the pure protein involves over-expression of the pET-plasmid-encoded gene in E. coli, purification and solubilisation of inclusion bodies, refolding of the denatured protein and its purification by the consecutive affinity and size-exclusion chromatography steps. The urea-facilitated denaturation and dilution/dialysis-mediated refolding are the critical ste...

Chemotaxis and motility have been shown to play important roles in Campylobacter jejuni pathogenesis by promoting bacterial colonisation and invasion of the host1,2,3. Chemotaxis allows bacteria to move towards an optimal environment for growth, as guided by chemical signals. This process involves recognition of intracellular and environmental chemical cues by a set of proteins termed chemoreceptors, or transducer-like proteins (Tlps). Most chemoreceptors are membrane-embedded proteins with an extracytoplasmic ligand binding domain (LBD), a transmembrane domain and a cytoplasmic signalling domain, the latter of which interacts with the cytosolic signalling proteins that transmit the signal to the flagellar motors4,5,6,7.
Eleven different chemoreceptors have been identified in the C. jejuni genome4,8. To date, only some of these chemoreceptors have been characterised and the ligand specificity of Tlp19, Tlp310,11, Tlp411, Tlp712, and Tlp1113 is known. Identification of natural ligands of the remaining chemoreceptors in this species, and numerous chemoreceptors in other bacteria, can be greatly facilitated by the production of folded and highly pure recombinant chemoreceptor LBDs14,15,16. However, attempts to heterologously express periplasmic LBDs of bacterial chemoreceptors in Escherichia coli often result in their targeting into inclusion bodies17,18,19. Nevertheless, this phenomenon can facilitate easy isolation and recovery of the protein in hand. Here, a method is presented for protein recovery from inclusion bodies, its refolding and purification, using the periplasmic LBD of the C. jejuni chemoreceptor Tlp3 as an example. This example was chosen because Tlp3-LBD belongs to the dCACHE family20 of sensing domains which are abundantly found in two-component histidine kinases and chemoreceptors in prokaryotes20,21,22,23.
In this approach, the expression construct, based on a pET151/D-TOPO vector, has been designed to incorporate an N-terminal His6-tag followed by a tobacco etch virus (TEV) protease cleavage site, for subsequent tag removal19. The protocol describes protein overexpression in E. coli, isolation and urea-mediated solubilisation of inclusion bodies, and protein refolding by urea depletion. Following refolding, the sample is purified by affinity chromatography, with optional tag removal and size-exclusion chromatography. The folded state of the purified protein is confirmed using circular dichroism spectroscopy. This is a modified version of the method that has been previously developed to recover and purify the LBD of a different chemoreceptor, Helicobacter pylori TlpC19. This procedure, summarised in Figure 1, yields 10 - 20 mg of pure, untagged Tlp3-LBD per 1 L of bacterial culture, with a protein purity of &#62;90% as estimated by SDS-PAGE.

<table><tbody><tr><td>Tris base</td><td>AMRESCO</td><td>497</td><td></td></tr><tr><td>Sodium chloride (NaCl)</td><td>MERK MILLIPORE</td><td>1064041000</td><td></td></tr><tr><td>Ampicillin</td><td>G-BIOSCIENCES</td><td>A051-B</td><td></td></tr><tr><td>Phenylmethanesulfonyl fluoride (PMSF)</td><td>MERCK</td><td>52332</td><td></td></tr><tr><td>Triton x-100</td><td>AMRESCO</td><td>694</td><td></td></tr><tr><td>Isopropyl &amp;beta;-D-thiogalactoside (IPTG)</td><td>ASTRAL SCIENTIFIC PTY LTD</td><td>AST0487</td><td></td></tr><tr><td>Urea</td><td>AMRESCO</td><td>VWRC0568</td><td></td></tr><tr><td>Dithiothreitol</td><td>ASTRAL SCIENTIFIC PTY LTD</td><td>C-1029</td><td></td></tr><tr><td>L-arginine monohydrochloride</td><td>SIGMA-ALDRICH</td><td>A5131</td><td></td></tr><tr><td>Reduced L-glutathione</td><td>SIGMA-ALDRICH</td><td>G4251</td><td></td></tr><tr><td>Oxidized L-glutathione</td><td>SIGMA-ALDRICH</td><td>G4376</td><td></td></tr><tr><td>Sodium phosphate dibasic (Na&lt;sub&gt;2&lt;/sub&gt;HPO&lt;sub&gt;4&lt;/sub&gt;)</td><td>SIGMA-ALDRICH</td><td>7558-79-4</td><td></td></tr><tr><td>Sodium phosphate monobasic (NaH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;)</td><td>SIGMA-ALDRICH</td><td>10049-21-5</td><td></td></tr><tr><td>Ethylenediaminetetraacetic acid disodium salt dehydrate (EDTA)</td><td>AMRESCO</td><td>VWRC20302.260</td><td></td></tr><tr><td>Imidazole</td><td>SIGMA-ALDRICH</td><td>I2399</td><td></td></tr><tr><td>Glycerol</td><td>ASTRAL SCIENTIFIC PTY LTD</td><td>BIOGB0232</td><td></td></tr><tr><td>Nickel chloride (NiCl&lt;sub&gt;2&lt;/sub&gt;)</td><td>SIGMA-ALDRICH</td><td>339350</td><td></td></tr><tr><td>Glycine</td><td>AMRESCO</td><td>VWRC0167</td><td></td></tr><tr><td>Sodium dodecyl sulfate (SDS)</td><td>SIGMA-ALDRICH</td><td>L4509</td><td></td></tr><tr><td>Unstained Protein Ladder, Broad Range (10-250 kDa)</td><td>NEW ENGLAND BIOLABS</td><td>P7703</td><td></td></tr><tr><td>Amicon Ultracel centrifugal concentrator (Millipore)</td><td>MERCK</td><td>UFC901096</td><td></td></tr><tr><td>50 mL Falcon tube</td><td>FALCON</td><td>BDAA352070</td><td></td></tr><tr><td>Dialysis tubing</td><td>LIVINGSTONE INTERNATIONAL PTY</td><td>Dialysis</td><td></td></tr><tr><td>Snakeskin dialysis tubing</td><td>THERMO SCIENTIFIC&amp;trade;</td><td>68100</td><td></td></tr><tr><td>Prepacked HiTrap Chelating HP column</td><td>GE HEALTHCARE LIFE SCIENCES</td><td>17-0408-01</td><td></td></tr><tr><td>EmulsiFlex-C5 high-pressure homogeniser</td><td>AVESTIN</td><td>EmulsiFlex&amp;trade; - C5</td><td></td></tr><tr><td>Peristaltic Pump P-1</td><td>GE HEALTHCARE LIFE SCIENCES</td><td>18-1110-91</td><td></td></tr><tr><td>Superdex 200 HiLoad 26/60 size-exclusion column&amp;nbsp;</td><td>GE HEALTHCARE LIFE SCIENCES</td><td>28989336</td><td></td></tr><tr><td>JASCO J-815 spectropolarimeter</td><td>JASCO</td><td>J-815</td><td></td></tr></tbody></table>

method for efficient refolding and purification of chemoreceptor ligand binding domain

Method for Efficient Refolding and Purification of Chemoreceptor Ligand Binding Domain

Identification of natural ligands of chemoreceptors and structural studies aimed at elucidation of the molecular basis of the ligand specificity can be greatly facilitated by the production of milligram amounts of pure, folded ligand binding domains. Attempts to heterologously express periplasmic ligand binding domains of bacterial chemoreceptors in Escherichia coli (E. coli) often result in their targeting into inclusion bodies. Here, a method is presented for protein recovery from inclusion bodies, its refolding and purification, using the periplasmic dCACHE ligand binding domain of Campylobacter jejuni (C. jejuni) chemoreceptor Tlp3 as an example. The approach involves expression of the protein of interest with a cleavable His6-tag, isolation and urea-mediated solubilisation of inclusion bodies, protein refolding by urea depletion, and purification by means of affinity chromatography, followed by tag removal and size-exclusion chromatography. The circular dichroism spectroscopy is used to confirm the folded state of the pure protein. It has been demonstrated that this protocol is generally useful for production of milligram amounts of dCACHE periplasmic ligand binding domains of other bacterial chemoreceptors in a soluble and crystallisable form.

Recombinant expression of His6-Tlp3-LBD in E. coli resulted in protein deposition in inclusion bodies. The expression yield from 1 L of bacterial culture calculated in step 2.13 was approximately 100 mg of His6-Tlp3-LBD deposited in inclusion bodies. The protein isolation procedure, described here and illustrated in Figure 1, consists of the solubilisation of inclusion bodies, protein refolding and purification, by means of affi...

A procedure is presented for the refolding of the dCACHE periplasmic ligand binding domain of Campylobacter jejuni chemoreceptor Tlp3 from inclusion bodies and the purification to yield milligram quantities of protein.

Identification of natural ligands of chemoreceptors and structural studies aimed at elucidation of the molecular basis of the ligand specificity can be ...

method-for-efficient-refolding-purification-chemoreceptor-ligand

Research

JoVE Journal

Biochemistry

We describe implementation of the REPLACE strategy for targeting protein-protein interactions. REPLACE is an iterative strategy involving synthetic and computational approaches for the conversion of optimized peptidic inhibitors into drug like molecules.

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Here, we describe methods that we commonly employ in the laboratory to determine how the nature of the interaction between the T-cell receptor and tumor antigens, presented by human leukocyte antigens, governs T-cell functionality; these methods include protein production, X-ray crystallography, biophysics, and functional T-cell experiments.

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

A protocol for high-precision FRET experiments at the single molecule level is presented here. Additionally, this methodology can be used to identify three conformational states in the ligand-binding domain of the N-methyl-D-aspartate (NMDA) receptor. Determining precise distances is the first step towards building structural models based on FRET experiments.

High Precision FRET at Single-molecule Level for Biomolecule Structure Determination

This study presents a detailed procedure to perform single-molecule fluorescence resonance energy transfer (smFRET) experiments on G protein-coupled receptors (GPCRs) using site-specific labeling via unnatural amino acid (UAA) incorporation. The protocol provides a step-by-step guide for smFRET sample preparation, experiments, and data analysis.

Visualizing the Conformational Dynamics of Membrane Receptors Using Single-Molecule FRET

This protocol introduces the tools available for modeling small-molecule ligands in cryoEM maps of macromolecules.

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

We describe a methodology based on sequence diversification to estimate the amino acid preferences of multispecific binding sites in protein-protein interactions (PPIs). In this strategy, thousands of potential peptide ligands are generated and screened in silico, thus overcoming some limitations of available experimental methods.

Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions

Here, we present a protocol for the structure-guided design of protein-ligand binding interaction between Sanglifehrin A and Cyclophilin A/Ganoderiol-F, essential in discovering new drugs. The stability of the ligand-receptor complex was evaluated using molecular dynamics simulation.

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Protein design involves the construction of amino acid sequences and the incorporation of specific motifs to create functional variants. This approach is critical for the development of antimicrobial peptides (AMPs) to combat antibiotic-resistant pathogens. This paper presents a procedure for protein construction using various bioinformatics tools.

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

A protocol to synthesize peptoids with mixed cationic functionality in the same sequence is presented (lysine- and arginine-type monomers). Subsequent testing of these compounds against Leishmania mexicana, the protozoan parasites that cause cutaneous leishmaniasis, is also described.

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

We have succeeded in establishing a method for RNA isolation from plant seeds containing large amounts of oils, proteins, and polyphenols, which have inhibitory effects on high-purity RNA isolation. Our method is suitable for monitoring the expression of genes with low level transcripts in seeds.

An Efficient Method for the Isolation of Highly Purified RNA from Seeds for Use in Quantitative Transcriptome Analysis

Learn efficient refolding and purification of the Tlp3 chemoreceptor ligand binding domain from inclusion bodies using E. coli expression. This method yields milligram quantities of functional protein for structural studies and ligand screening.

Method for Efficient Refolding and Purification of Chemoreceptor Ligand Binding Domain

Explore More Videos